Cantuzumab is a engineered antibody specifically targeting MUC1, a mucin frequently upregulated in various malignancies , including pancreatic carcinoma . Its approach involves binding to MUC1, triggering https://cantuzumab-bulk-supply172075.mpeblog.com/76329533/cantuzumab-a-deep-dive-into-the-anti-muc1-antibody